Cardiac Surgery

Cardiac surgery, commonly referred to as cardiovascular surgery, is a specialist area of surgery that is concerned with the treatment of conditions and diseases that affect the heart and blood vessels. Cardiac surgeons are skilled health care professionals who carry out surgical treatments to repair, replace, or modify the heart, blood vessels, and surrounding structures. These procedures are often carried out to improve the cardiovascular system's functioning and treat life-threatening illnesses or their symptoms.

The following are some common cardiac surgery procedures:

1. Coronary Artery Bypass Grafting (CABG): Coronary artery bypass grafting (CABG), often known as bypass surgery, is a treatment used to treat coronary artery disease (CAD). To bypass blocked or narrowed coronary arteries and improve blood flow to the heart muscle, surgeons extract a healthy blood vessel from another area of the body, typically the leg or chest.

2. Valve Surgery: Repairing or replacing damaged or defective heart valves is known as valve surgery. Stenosis (a constriction) and regurgitation (a leaking) are two disorders that can affect the heart valves. The valve can either be fixed surgically or replaced with a mechanical or bioprosthetic valve.

3. Aneurysm Repair: Aneurysms are abnormal bulges or weakness in blood vessels, and they can be dangerous if they occur in the aorta (the body's biggest artery). Aortic aneurysms can be replaced or repaired by cardiac surgeons, lowering the risk of rupture.

4. Congenital Heart Defect Repair: Congenital heart defects are heart abnormalities that some people have from birth. Corrective surgeries can be carried out by cardiac surgeons to fix these flaws and improve the heart's performance.

5. Arrhythmia Surgery: Surgery, such as the Maze procedure, can be used to generate scar tissue in the heart to disrupt abnormal electrical pathways and restore a normal heart rhythm in situations with severe arrhythmias (abnormal heart rhythms) that do not respond to other treatments.

6. Heart Transplantation: Heart transplantation may be the only option if the heart is severely damaged and cannot be repaired. The failing patient's heart is replaced with a healthy donor heart by cardiac surgeons working with transplant teams.

7. Left Ventricular Assist Device (LVAD) Placement: For a weak heart to pump blood more efficiently, mechanical devices called LVADs are implanted in the chest. When a patient is not a candidate for a heart transplant, they are frequently used as a bridge to heart transplantation or as a destination therapy.

8. Minimally Invasive Cardiac Surgery: Minimally invasive procedures have become more popular in heart surgery during the past few years. These procedures have a quicker recovery period and less scarring since they use small incisions and use specialized instruments.

A highly qualified and specialized team, including cardiac surgeons, anesthesiologists, nurses, and other medical professionals, is needed for the complex and delicate field of cardiac surgery. It is frequently carried out in hospitals with specialized heart surgery units or cardiac surgery centers.

In order to decide the most appropriate plan of treatment for their specific condition, patients often go through a thorough evaluation before having cardiac surgery. The patient's diagnosis, overall health, and unique circumstances all play a role in the surgical technique selection. The results and quality of life for many people with heart conditions have improved as a result of considerable advancements in cardiac surgery over time.

Subtopics

Perioperative Management | Surgery for ischemic Heart Disease | Surgery for Valvular Heart Disease | Surgery for Heart Failure | Thoracic Aortic Disease | Surgery for Cardiac Rhythm Disorders and Tumors | Surgery for Congenital Heart Disease

Market Statistics:

The global market for cardiac surgical instruments is predicted to reach USD 1.63 billion by 2022, up from USD 1.16 billion in 2017, at a CAGR of 7.1%.

Europe dominated the global market in 2017, followed by North America. The European market is primarily driven by increased use of surgical treatments in cardiology, expansion in the European healthcare sector, and public awareness campaigns. The Asian market, on the other hand, is expected to grow at the fastest CAGR due to increased government and private sector spending in healthcare, rising purchasing power, and a high prevalence of cardiac disorders. China, India, and Japan are three of Asia's most important marketplaces.